Dapagliflozin During Exercise for the PrevenTion of Hypoglycaemia

NCT03537131 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Temporary halt due to COVID-19 pandemic

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Dapagliflozin 10 MG Oral Tablet

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]